Literature DB >> 22230579

Cloned cDNA of A/swine/Iowa/15/1930 internal genes as a candidate backbone for reverse genetics vaccine against influenza A viruses.

Porntippa Lekcharoensuk1, Witthawat Wiriyarat, Nantawan Petcharat, Chalermpol Lekcharoensuk, Prasert Auewarakul, Juergen A Richt.   

Abstract

Reverse genetics viruses for influenza vaccine production usually utilize the internal genes of the egg-adapted A/Puerto Rico/8/34 (PR8) strain. This egg-adapted strain provides high production yield in embryonated eggs but does not necessarily give the best yield in mammalian cell culture. In order to generate a reverse genetics viral backbone that is well-adapted to high growth in mammalian cell culture, a swine influenza isolate A/swine/Iowa/15/30 (H1N1) (rg1930) that was shown to give high yield in Madin-Darby canine kidney (MDCK) cells was used as the internal gene donor for reverse genetics plasmids. In this report, the internal genes from rg1930 were used for construction of reverse genetics viruses carrying a cleavage site-modified hemagglutinin (HA) gene and neuraminidase (NA) gene from a highly pathogenic H5N1 virus. The resulting virus (rg1930H5N1) was low pathogenic in vivo. Inactivated rg1930H5N1 vaccine completely protected chickens from morbidity and mortality after challenge with highly pathogenic H5N1. Protective immunity was obtained when chickens were immunized with an inactivated vaccine consisting of at least 2(9) HA units of the rg1930H5N1 virus. In comparison to the PR8-based reverse genetics viruses carrying the same HA and NA genes from an H5N1 virus, rg1930 based viruses yielded higher viral titers in MDCK and Vero cells. In addition, the reverse genetics derived H3N2 and H5N2 viruses with the rg1930 backbone replicated in MDCK cells better than the cognate viruses with the rgPR8 backbone. It is concluded that this newly established reverse genetics backbone system could serve as a candidate for a master donor strain for development of inactivated influenza vaccines in cell-based systems.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22230579      PMCID: PMC3274597          DOI: 10.1016/j.vaccine.2011.12.109

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  41 in total

Review 1.  Evolution and ecology of influenza A viruses.

Authors:  R G Webster; W J Bean; O T Gorman; T M Chambers; Y Kawaoka
Journal:  Microbiol Rev       Date:  1992-03

2.  Molecular evolution of H5N1 in Thailand between 2004 and 2008.

Authors:  Kamol Suwannakarn; Alongkorn Amonsin; Jiroj Sasipreeyajan; Pravina Kitikoon; Rachod Tantilertcharoen; Sujira Parchariyanon; Arunee Chaisingh; Bandit Nuansrichay; Thaweesak Songserm; Apiradee Theamboonlers; Yong Poovorawan
Journal:  Infect Genet Evol       Date:  2009-06-16       Impact factor: 3.342

3.  Planning and executing a vaccination campaign against avian influenza.

Authors:  S Marangon; A Cristalli; L Busani
Journal:  Dev Biol (Basel)       Date:  2007

4.  Efficacy of avian influenza vaccine in poultry: a meta-analysis.

Authors:  Shu-Mei Hsu; Tony Hsiu-Hsi Chen; Ching-Ho Wang
Journal:  Avian Dis       Date:  2010-12       Impact factor: 1.577

5.  Characterization of the reconstructed 1918 Spanish influenza pandemic virus.

Authors:  Terrence M Tumpey; Christopher F Basler; Patricia V Aguilar; Hui Zeng; Alicia Solórzano; David E Swayne; Nancy J Cox; Jacqueline M Katz; Jeffery K Taubenberger; Peter Palese; Adolfo García-Sastre
Journal:  Science       Date:  2005-10-07       Impact factor: 47.728

6.  Eight-plasmid system for rapid generation of influenza virus vaccines.

Authors:  Erich Hoffmann; Scott Krauss; Daniel Perez; Richard Webby; Robert G Webster
Journal:  Vaccine       Date:  2002-08-19       Impact factor: 3.641

7.  Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia.

Authors:  K S Li; Y Guan; J Wang; G J D Smith; K M Xu; L Duan; A P Rahardjo; P Puthavathana; C Buranathai; T D Nguyen; A T S Estoepangestie; A Chaisingh; P Auewarakul; H T Long; N T H Hanh; R J Webby; L L M Poon; H Chen; K F Shortridge; K Y Yuen; R G Webster; J S M Peiris
Journal:  Nature       Date:  2004-07-08       Impact factor: 49.962

8.  Vaccination of chickens against H5N1 avian influenza in the face of an outbreak interrupts virus transmission.

Authors:  Trevor M Ellis; Connie Y H C Leung; Mary K W Chow; Lucy A Bissett; William Wong; Yi Guan; J S Malik Peiris
Journal:  Avian Pathol       Date:  2004-08       Impact factor: 3.378

9.  Novel swine influenza virus subtype H3N1, United States.

Authors:  Porntippa Lekcharoensuk; Kelly M Lager; Ramesh Vemulapalli; Mary Woodruff; Amy L Vincent; Jürgen A Richt
Journal:  Emerg Infect Dis       Date:  2006-05       Impact factor: 6.883

10.  Genome analysis linking recent European and African influenza (H5N1) viruses.

Authors:  Steven L Salzberg; Carl Kingsford; Giovanni Cattoli; David J Spiro; Daniel A Janies; Mona Mehrez Aly; Ian H Brown; Emmanuel Couacy-Hymann; Gian Mario De Mia; Do Huu Dung; Annalisa Guercio; Tony Joannis; Ali Safar Maken Ali; Azizullah Osmani; Iolanda Padalino; Magdi D Saad; Vladimir Savić; Naomi A Sengamalay; Samuel Yingst; Jennifer Zaborsky; Olga Zorman-Rojs; Elodie Ghedin; Ilaria Capua
Journal:  Emerg Infect Dis       Date:  2007-05       Impact factor: 6.883

View more
  6 in total

1.  G45R mutation in the nonstructural protein 1 of A/Puerto Rico/8/1934 (H1N1) enhances viral replication independent of dsRNA-binding activity and type I interferon biology.

Authors:  Challika Kaewborisuth; Mark Zanin; Hans Häcker; Richard J Webby; Porntippa Lekcharoensuk
Journal:  Virol J       Date:  2016-07-12       Impact factor: 4.099

2.  Natural Phytochemicals, Luteolin and Isoginkgetin, Inhibit 3C Protease and Infection of FMDV, In Silico and In Vitro.

Authors:  Sirin Theerawatanasirikul; Nattarat Thangthamniyom; Chih-Jung Kuo; Ploypailin Semkum; Nantawan Phecharat; Penpitcha Chankeeree; Porntippa Lekcharoensuk
Journal:  Viruses       Date:  2021-10-21       Impact factor: 5.048

3.  Andrographolide and Deoxyandrographolide Inhibit Protease and IFN-Antagonist Activities of Foot-and-Mouth Disease Virus 3Cpro.

Authors:  Sirin Theerawatanasirikul; Varanya Lueangaramkul; Nattarat Thangthamniyom; Penpitcha Chankeeree; Ploypailin Semkum; Porntippa Lekcharoensuk
Journal:  Animals (Basel)       Date:  2022-08-07       Impact factor: 3.231

4.  A Novel Plasmid DNA-Based Foot and Mouth Disease Virus Minigenome for Intracytoplasmic mRNA Production.

Authors:  Ploypailin Semkum; Challika Kaewborisuth; Nattarat Thangthamniyom; Sirin Theerawatanasirikul; Chalermpol Lekcharoensuk; Payuda Hansoongnern; Pongrama Ramasoota; Porntippa Lekcharoensuk
Journal:  Viruses       Date:  2021-06-01       Impact factor: 5.048

5.  In silico and in vitro analysis of small molecules and natural compounds targeting the 3CL protease of feline infectious peritonitis virus.

Authors:  Sirin Theerawatanasirikul; Chih Jung Kuo; Nanthawan Phetcharat; Porntippa Lekcharoensuk
Journal:  Antiviral Res       Date:  2019-12-18       Impact factor: 5.970

6.  Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.

Authors:  Sirin Theerawatanasirikul; Chih Jung Kuo; Nanthawan Phecharat; Jullada Chootip; Chalermpol Lekcharoensuk; Porntippa Lekcharoensuk
Journal:  Antiviral Res       Date:  2020-09-07       Impact factor: 5.970

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.